Blog

Month: February 2017

Toronto, Ontario – February 28, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries today reported financial results for the three months and full year ended December 31, 2016. Unless otherwise indicated, all dollar … Continue reading “NOVADAQ Announces Fourth Quarter and Full Year 2016 Financial Results”

DermACELL receives coverage from Cigna

Posted on February 2, 2017

LifeNet Health is proud that Cigna Health Insurance is now covering Dermacell when used in association with covered medically necessary breast reconstruction procedures. Dermacell AWM has also been approved for coverage as medically necessary for diabetic foot ulcers when the following criteria are met: partial- or full-thickness diabetic foot ulcers of greater than four weeks … Continue reading “DermACELL receives coverage from Cigna”

Toronto, Ontario – February 15, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it will release financial results for the fourth quarter and full year 2016 after the close of … Continue reading “NOVADAQ TO REPORT FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS ON FEBRUARY 28, 2017”

Toronto, Ontario – February 8, 2017 – NOVADAQ Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it plans to participate in two upcoming investor conferences. Rick Mangat, President and Chief Executive Officer, is … Continue reading “NOVADAQ ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES”